Anaplastic Thyroid Carcinoma: Treatment in the Age of Molecular Targeted Therapy

DOI Web Site 1 Citations

Search this article

Description

<jats:p>Anaplastic thyroid carcinoma is one of the most aggressive and deadly cancers in humans and accounts for one to two cases per million persons annually. The rarity of this malignancy and the rapidity by which it grows has been a major barrier to progress in finding effective therapies. Thus, the treatment that is the current standard of care for these patients is largely palliative, and few are cured; however, novel therapies and approaches are being studied in patients with anaplastic thyroid carcinoma and are delineated herein.</jats:p>

Journal

Citations (1)*help

See more

Details 詳細情報について

Report a problem

Back to top